LAB
LAB
NASDAQ · Life Sciences Tools & Services

Standard Biotools Inc

$0.62
+0.01 (+1.04%)
As of Nov 7, 2:03 AM ET ·
Financial Highlights (FY 2026)
Revenue
88.28M
Net Income
-77,497,360
Gross Margin
49.9%
Profit Margin
-87.8%
Rev Growth
-4.5%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 49.9% 49.9% 33.5% 33.5%
Operating Margin -129.2% -116.3% 10.2% 9.7%
Profit Margin -87.8% -83.4% 8.2% 10.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 88.28M 92.42M 337.87M 394.49M
Gross Profit 44.01M 46.08M 113.16M 132.12M
Operating Income -114,051,478 -107,460,563 34.61M 38.43M
Net Income -77,497,360 -73,018,869 27.76M 42.76M
Gross Margin 49.9% 49.9% 33.5% 33.5%
Operating Margin -129.2% -116.3% 10.2% 9.7%
Profit Margin -87.8% -83.4% 8.2% 10.8%
Rev Growth -4.5% -4.5% +3.9% -1.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 73.7K 73.7K 57.07M 49.88M
Total Equity 122.79M 122.79M 239.14M 240.02M
D/E Ratio 0.00 0.00 0.24 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -104,461,546 -103,892,869 49.10M 55.88M
Free Cash Flow — — 19.25M 25.05M